Publication | Closed Access

A semi-automated mass spectrometric immunoassay coupled to selected reaction monitoring (MSIA–SRM) reveals novel relationships between circulating PCSK9 and metabolic phenotypes in patient cohorts

Metabolic SyndromeMedicineMass SpectrometryImmunologyBiological Mass SpectrometryPathologyMetabolic PhenotypesMetabolomic ProfilingReaction MonitoringBiomarker DiscoveryPatient CohortsMetabolic ProfilingMetabolic SignalingMolecular DiagnosticsExposomics